Lord, Abbett & Co’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-239,554
| Closed | -$29M | – | 603 |
|
|
2023
Q1 | $29M | Buy |
239,554
+32,689
| +16% | +$3.95M | 0.1% | 282 |
|
|
2022
Q4 | $23.8M | Buy |
206,865
+105,177
| +103% | +$12.1M | 0.08% | 318 |
|
|
2022
Q3 | $10.3M | Sell |
101,688
-4,274
| -4% | -$433K | 0.04% | 402 |
|
|
2022
Q2 | $10.7M | Buy |
105,962
+32,159
| +44% | +$3.26M | 0.04% | 398 |
|
|
2022
Q1 | $8.59M | Buy |
+73,803
| New | +$8.59M | 0.02% | 480 |
|
|
2020
Q4 | – | Sell |
-165,974
| Closed | -$18.6M | – | 714 |
|
|
2020
Q3 | $18.6M | Sell |
165,974
-41
| -0% | -$4.59K | 0.06% | 389 |
|
|
2020
Q2 | $17.4M | Buy |
+166,015
| New | +$17.4M | 0.06% | 397 |
|